Library

Displaying 901 - 925 of 2,573

Hematology Session III
Hematology Session III
By: Francine Foss, Eduardo Sotomayor, Nakhle Saba
T-Cell NHL: What’s New?
T-Cell NHL: What’s New?
By: Francine M. Foss, MD
CLL: Novel Therapies
CLL: Novel Therapies
By: Javier Pinilla-Ibarz, MD
Other Driver Mutations: cMET, B-RAF, RET, NTRK
Other Driver Mutations: cMET, B-RAF, RET, NTRK
By: Luis E. Raez, MD, FACP, FCCP
Lymphoma and CLL 2024 Updates
Lymphoma and CLL 2024 Updates
By: Maxwell M. Krem, MD, PhD
AML and MDS: New Directions
AML and MDS: New Directions
By: Olatoyosi Odenike, MD
Anticoagulation in the Oncology Patient
Anticoagulation in the Oncology Patient
By: Pamela Dudkiewicz, ARPN
MDS: State of the Art
MDS: State of the Art
By: Paul Koller, MD
Hematology Session I
Hematology Session I
By: Rami Komrokji, Mohamed Kharfan-Dabaja, Guillermo Garcia-Manero
Hematology Session II
Hematology Session II
By: Sikander Ailawadhi, Javier Pinilla-Ibarz, Lisa Welsh
Waldenstrom’s Macroglobulinemia
Waldenstrom’s Macroglobulinemia
By: Steven P. Treon, MD, PhD, ,FACP, FRCP
Waldenstrom’s Macroglobulinemia
Waldenstrom’s Macroglobulinemia
By: Steven P. Treon, MD, PhD, ,FACP, FRCP
Management of Immune Related Adverse Events
Management of Immune Related Adverse Events
By: Alicia Rigby, RN, MSN, FNP, AOCNP
Management of Immune Related Adverse Events
Management of Immune Related Adverse Events
By: Alicia Rigby, RN, MSN, FNP, AOCNP
Advances in Immunotherapy
Advances in Immunotherapy
By: Arta M Monjazeb - MD - PhD
Systemic Immunotherapy Combinations
Systemic Immunotherapy Combinations
By: Arta M Monjazeb, MD, PhD
Advances in Immunotherapy
Advances in Immunotherapy
By: Arta M. Monjazeb, MD, PhD